Read, Stephanie H. http://orcid.org/0000-0002-2087-7358
Quignot, Nadia http://orcid.org/0000-0001-8718-1307
Kapso-Kapnang, Raissa
Comerford, Erin
Zheng, Ying
Gainford, Corona
Sasane, Medha
Vataire, Anne-Lise http://orcid.org/0000-0002-3354-3189
Delzongle, Laure
Bidard, Francois-Clement http://orcid.org/0000-0001-5932-8949
Funding for this research was provided by:
Sanofi
Article History
Received: 13 September 2023
Accepted: 26 November 2023
First Online: 11 January 2024
Declarations
:
: FC Bidard received research support from Pfizer, Prolynx, Merck KGaA, Rain Oncology, Roche, Seagen; consultancy honoraria from Astra-Zeneca, Caris, Daiichi-Sankyo, Exact Sciences, GE Healthcare, Gilead, GSK, Inatherys, Lilly, Menarini/Stemline, Novartis, Rain Oncology, Sanofi, Seagen; speaker fees from Astra-Zeneca, Daiichi-Sankyo, Lilly, Menarini/Stemline, Pfizer, Rain Oncology, Sanofi, Seagen; support for congress attendance from Astra-Zeneca, Pfizer and Novartis. E Comerford, Y Zheng, C Gainford, M Sasane, AL Vataire and L Delzongle are all employees of Sanofi. SH Read, N Quignot and R Kapso-Kapnang are full-time employees at Certara and received consulting fees to independently conduct this study.
: This study has been approved by the French ‘Commission Nationale Informatique et Libertés’ (CNIL) governing the data access and the data privacy laws.
: As this study involved anonymized structured data, which according to applicable legal requirements do not contain data subject to privacy laws, obtaining informed consent from patients was not required.
: As this study involved anonymized structured data, which according to applicable legal requirements do not contain data subject to privacy laws, obtaining consent to publish from patients was not required.